CELL AND GENE THERAPY INSIGHTS

June 2024 Issue

Volume 10 Issue 5

Cell and Gene Therapy Insights Volume 10 Issue 5

Featuring

Issue Spotlight: Viral and non-viral vector platform evolution
Vectors focus: Upstream processing 2024
Other articles
Webinars

SPOTLIGHT

Viral and non-viral vector platform evolution
Zhenghong Gao
Guest Editor:
Zhenghong Gao, Director, Non-Viral Delivery at AskBio

Foreword

Viral and non-viral vector platform evolution

Viral and non-viral vector platform evolution

Zhenghong Gao
19 June 2024
Read

Review

Switching from ex vivo to in vivo: approaches and considerations for generating cell therapies directly in the patient upon in vivo gene delivery

Switching from ex vivo to in vivo: approaches and considerations for generating cell therapies directly in the patient upon in vivo gene delivery

Semih U Tareen
3 June 2024
Read
Self-replicating RNA for mRNA vaccine development

Self-replicating RNA for mRNA vaccine development

Kenneth Lundstrom
3 June 2024
Read

Innovator Insight

It’s a match: cell line engineering for AAV manufacturing expands the options for therapeutic programs

It’s a match: cell line engineering for AAV manufacturing expands the options for therapeutic programs

Dovile Woods
27 August 2024
Read

Commentary

What are the issues associated with developing gene therapies for rare disease and are the current development models working?

What are the issues associated with developing gene therapies for rare disease and are the current development models working?

Samir Nuseibeh, Els Henckaerts
20 June 2024
Read

FastFacts

Get your non-viral T cell engineering process ready for clinical manufacturing

Get your non-viral T cell engineering process ready for clinical manufacturing

Melanie Rietenbach
5 June 2024
Read

Viewpoint

Expanding the therapeutic index of lipid nanoparticles: potential key for clinical translation success

Expanding the therapeutic index of lipid nanoparticles: potential key for clinical translation success

Zhenghong Gao
12 June 2024
Read

Interview

Developing focused ultrasound as a novel gene delivery tool to overcome the blood–brain barrier

Developing focused ultrasound as a novel gene delivery tool to overcome the blood–brain barrier

Rikke Hahn Kofoed
29 May 2024
Read
Advancing capsid engineering: improving tropism and delivery efficiency of AAV

Advancing capsid engineering: improving tropism and delivery efficiency of AAV

Li Ou
26 March 2024
Read

Vectors FOCUS

Upstream processing 2024

Expert Insight

Upstream processing of viral vectors: a summary

Upstream processing of viral vectors: a summary

Pardhasaradhi Mathi
29 July 2024
Read

Interview

Revolutionizing AAV manufacturing: innovations in process and capsid development

Revolutionizing AAV manufacturing: innovations in process and capsid development

Michael DiBiasio-White
3 June 2024
Read

Journal articles

Innovator Insight

Alternative solutions to separate AAV full and empty capsids using anion exchange

Alternative solutions to separate AAV full and empty capsids using anion exchange

Åsa Hagner-McWhirter, Mark Schofield
24 June 2024
Read
Increasing efficiency in AAV-based gene therapy production: platform optimization with multiserotype AAV affinity capture

Increasing efficiency in AAV-based gene therapy production: platform optimization with multiserotype AAV affinity capture

Nicolas Laroudie, Tiago Albano
20 June 2024
Read
Analytical strategies for sterility and mycoplasma testing in biotherapies: from early development to production scale-up

Analytical strategies for sterility and mycoplasma testing in biotherapies: from early development to production scale-up

Sharon Rouw, Michael Brewer
17 June 2024
Read
Commercial-scale manufacture of lentivirus for ex vivo and in vivo therapies

Commercial-scale manufacture of lentivirus for ex vivo and in vivo therapies

Rachel Legmann, Michelle Yen Tran
4 June 2024
Read
Can primary packaging selection help mitigate particulate risks in cell and gene therapy manufacturing?

Can primary packaging selection help mitigate particulate risks in cell and gene therapy manufacturing?

Sean Werner, Joshua Jendusa, Stuart Curbishley
4 June 2024
Read

Commentary

Navigating the EU joint clinical assessment process: key considerations for manufacturers of ATMPs and oncology medicines

Navigating the EU joint clinical assessment process: key considerations for manufacturers of ATMPs and oncology medicines

Clare L Hague
18 June 2024
Read

Infographic

mRNA purification: 5 key pieces of expert advice

mRNA purification: 5 key pieces of expert advice

27 June 2024
Read

Conference Insight

2023 NIFDS-PMDA-USP Workshop for Advanced Therapies, day 1

2023 NIFDS-PMDA-USP Workshop for Advanced Therapies, day 1

M Kim, B Clarke, C G Chase et al.
4 June 2024
Read

Webinars